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a b s t r a c t
Farnesol, a compound widely found in several agro-food by-products, is an important bioactive agent that
can be exploited in cosmetics and pharmaceutics but the direct bioapplication of this compound is limited by
its volatility. Here the entrapment of farnesol in silica capsules was investigated to control the release of this
bioactive compound in the vapor phase and in ethanol solutions. The preparation of silica capsules with oil
cores was obtained by employing a sol–gel method using O/W/Omultiple emulsions. Two distinct chemical
vehicles for farnesol have been investigated, retinol and oleic acid, that afterwards have been emulsiﬁed
as internal oil phases. The volatile release of farnesol from the as-prepared SiO2 capsules was investigated
by headspace solid phase microextraction (HS-SPME) followed by gas chromatographic analysis (GC), and
the release to ethanol was carried out by direct injection of the ethanolic fraction into the GC system. It
is demonstrated that these capsules are efﬁcient for the long controlled release of farnesol and that the
respective proﬁles depend on the chemical parameters employed in the synthesis of the capsules.
c© 2012 Elsevier B.V. All rights reserved.
1. Introduction
Over the past decade, amajor trend in the emerging area of encap-
sulation technology has been the design of increasingly sophisticated
capsules for controlled release of bioactive molecules [1,2]. These
materials ﬁnd many applications in a wide spectrum of ﬁelds such as
medicine, pharmaceutics, food and paint industries [3]. In addition,
it is known that the encapsulation of materials using inorganic parti-
cles and organic polymers can alter the surface characteristics of the
cores and enhance the storage stability of the entrappedmaterials [1].
Diverse nanocarriers for drug delivery applications have been investi-
gated, these include liposomes [4], cyclodextrines [5], colloidosomes
[6], silica microcapsules [1–3] and metal-organic frameworks [7].
In particular, there has been an increasing interest in the develop-
ment of mesoporous and hollow SiO2 materials for controlled drug
delivery due to their attractive features [8–11]. In fact, owing to their
chemical robustness and biocompatibility, silica capsules offer an in-
teresting alternative to pure organic based delivery systems, which
generally show lower drug loading capability and rapid drug release.
Several methods for the preparation of silica capsules have been de-
veloped, these include Pickering emulsions [12,13], water-in-oil-in-
water multiple emulsion templating using sodium silicate as precur-
sor [14], water-in-oil (W/O) or oil-in-water (O/W) emulsions using
tetraethylorthosilicate (TEOS) as silica precursor [9,15–17]. Among
these systems, multiple emulsions, both of oil-in-water-in-oil (O/W/
O) or water-in-oil-in-water (W/O/W) type, have been used as a tool
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to drug delivery in speciﬁc body targets, by prolonging the release of
drugs with a short biological half-life [1]. Although less investigated,
O/W/O multiple emulsions are good candidates for the controlled
release and stabilization of lipophilic drugs [18]. In this context, the
entrapment and in vitro release of Vitamin A (retinol) in silica parti-
cles has been previously reported [1,19]. Additionally, a comparative
study for the stability of retinol in three types of emulsions: O/W,
W/O and O/W/O, has shown the highest stability when the O/W/O
emulsion was used [20].
Farnesol, a natural sesquiterpenoid (C15) occurs in many essen-
tial oils, mainly in rose and orange blossoms. Farnesol is a fragrance
ingredient widely used in cosmetics, ﬁne fragrances, shampoos, and
toilet soaps as well as in non-cosmetic products such as household
cleaners [21]. Also, recent studies have shown that farnesol affects
the growth of a number of bacteria and fungi, pointing to a potential
role as an antimicrobial agent [22,23]. For example, farnesol has been
incorporated into microcapsules that can be degraded by the action
of bacteria. These microcapsules, composed of natural proteins, were
ﬁlled with two active compounds that can be released upon reaching
targeted temperatures, allowing the delivery in perspiration condi-
tions [24].
Despite the relevance of farnesol in diverse applications, its use
has also been limited due to the volatility of this compound, lead-
ing to unnecessary losses. This research describes for the ﬁrst time
the entrapment of trans,trans-farnesol in SiO2 capsules using O/W/O
multiple emulsions. The emulsions act as soft organic templates to
produce amorphous SiO2 capsules by hydrolysis and condensation
reactions using TEOS as the sol/gel precursor. Due to their chemi-
cal and thermal stability and biocompatibility, silica capsules are an
2211-2863/$ - see front matter c© 2012 Elsevier B.V. All rights reserved.
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advantageous alternative to conventional pure organic based deliv-
ery systems (e.g. micelles, liposomes, and polymer particles), which
generally also show lower drug loading capability and rapid drug
release. It will be shown that oleic acid can be used as an efﬁcient
drug vehicle thus presenting economical advantages in relation to
the use of the more expensive vehicle retinol. In addition, with the
method here reported the surface of these SiO2 capsules can be easily
chemical functionalized in order to meet the demands in terms of
the release proﬁle of active substances. In principle, this process can
be adapted to the production of amorphous SiO2 capsules contain-
ing other volatile bioactive cores, but here this will be demonstrated
using SPME-GC-MS monitoring for farnesol releasing behavior.
2. Experimental
2.1. Materials
Tetraethyl orthosilicate (TEOS, 98%), polyoxyethylene sorbitan
monolaurate (Tween20), sorbitan monoleate (Span 80) N-decyl al-
cohol (>98%) were purchased from Sigma-Aldrich. Triblock copoly-
mer pluronic P123 (EO20PO70EO20,Mw. 5800), polyvinylpyridinone,
hydroxypropyl-cellulose (Mw. 100,000), polyethylene glycol, retinol
(95%) and oleic acid (90%) were also purchased from Aldrich Chemi-
cal Company. Ammonia (25%, Merck), ethanol (Riedel-de Hae¨n) and
trans,trans-farnesol (95%) Fluka (for sake of simplicity the term far-
nesol will be used therein). All the reagents were of analytical grade
and used without further puriﬁcation.
2.2. Preparation of multiple emulsions
O/W/O multiple emulsions were prepared through a two-step
emulsiﬁcation process. In a ﬁrst step, the primary O/Wemulsion was
prepared. Tween 20 as high HLB surfactant (1wt%) was added to an
aqueous solution containing a stabilizing polymer. The use of three
types of polymers (PEG, PVP and P123) was investigated. Farnesol
was added either to retinol or to oleic acid, and then dispersed in the
water phase. After 30min of stirring, NH4OH (2wt%) was added to
the water phase. In a second step the primary emulsion was slowly
added to n-decyl alcohol as external oil phase containing Span 80 as
low HLB surfactant (2wt%) and 0.8wt% HPC. The weight ratio of the
O/W primary emulsion in the external oil phase was kept at 1:9, and
the resulting O/W/O emulsionwas stirred at low shear for 30min. All
the experimental compositions are shown in Table 1.
2.3. Fabrication of silica capsules entrapping farnesol
To prepare silica capsules by the sol–gel method, an amount of
TEOS equivalent to themolar ratio H2O/TEOS= 4was gently added to
themultiple emulsions. Themixturewas then stirredwith amagnetic
stirrer for 7h at room temperature. After the reactionwas completed,
the sample was centrifuged at 3000 rpm for 15min; in order to re-
move non-reacted chemicals the as prepared particles were washed
twice with ethanol.
2.4. Characterization
The droplet size and morphology of the multiple emulsions were
investigated by optical microscopy using an Olympus BX51 micro-
scope. The FT-IR spectra of KBr pellets of the samples were recorded
by using a Mattson 7000 spectrometer, at 64 scans at a resolution of
4 cm−1. Transmission electron microscopy (TEM) was carried out on
a Hitachi H-9000microscope operating at 300kV. To prepare the TEM
samples, a drop of the diluted ethanolic solutions of the sampleswere
deposited on a carbon-coated copper grid, and the solvent was left to
evaporate. Scanning electron microscopy (SEM) images were carried
out using a Hitachi SU-70 and average sizes for the sample have been
estimated directly from the images.
2.5. Farnesol controlled release
In order to evaluate the release of farnesol from SiO2 capsules pre-
pared in a O/W/Omultiple emulsion, two assays were performed for
500h: the release to the vapor phase was evaluated using headspace
solid phase microextraction (HS-SPME) followed by gas chromato-
graphic analysis (GC), and the release to ethanol was carried out
by direct injection of the ethanolic fraction into the GC system.
For headspace sampling, ca 23.8–26.8mg of the SiO2 capsules with
1mL ethanol were introduced into a 2mL glass vial. The vial was
capped with a PTFE septum and a cap (Chromacol, Hertfordshire,
UK), and was stored at room temperature for 500h. At each sam-
pling moment, the SPME ﬁber was introduced for 10min into the
vial to promote the transfer of the farnesol from the headspace to
the coating ﬁber. The SPME device included a fused silica ﬁbre coat-
ing partially cross-linked with 50/30μm divinylbenzene-carboxen-
poly(dimethylsiloxane). For ethanol release assay, ca 39.5–41.1mg of
the SiO2 capsules and 2mL of ethanol were introduced into a 2mL
glass vial. At each sampling moment, 5μL of each ethanolic solution
was injected into a gas chromatograph. A PerkinElmer Clarus 400 gas
chromatograph with split injector and a ﬂame ionization detector
(FID) was used to performed both analysis (SPME and direct injection
of solutions), equipped with a 30m × 0.32mm (i.d.), 0.25μm ﬁlm
thickness DB-FFAP fused silica capillary column (J&W Scientiﬁc Inc.,
Folsom, CA, USA). The oven temperature was programmed from 100
to 200 ◦C at 20 ◦C/min (hold 1min at 200 ◦C). The injector and de-
tector temperatures were 250 ◦C. The ﬂow rate of the carrier gas (H2)
was set at 2.6mL/min. The injection port was lined with a 0.75mm
(i.d.) glass liner, in the case of SPME analysis. Split injection mode
was used (154mL/min). The GC area data were used as an approach
to estimate the relative content of farnesol.
3. Results and discussion
In this study, O/W/O multiple emulsions have been investigated
using various chemical compositions, which include the use of retinol
or oleic acid as vehicles for farnesol encapsulation. The preparedmul-
tiple emulsions were then employed as soft organic templates to
prepare silica capsules by a sol–gel method involving the hydroly-
sis and condensation of silane oligomers derived from TEOS used as
precursor. The hydrolysis and condensation reactions take place in
the water phase though TEOS was previously added to the oil phase
(n-decyl alcohol). This is because vigorous stirring of the external oil
phase facilitate the penetration of TEOS through the surfactant layer
surrounding the water phase in which the hydrolysis occur. As the
hydrolysis proceed, the water-soluble silica oligomers are kept inside
the aqueous droplet [1,8,9]. Thus the aqueous phase acts as space-
limiting micro-reactors for the hydrolysis process, and the internal
oil droplets serve as templates for cores.
The use of multiple emulsions in materials synthesis requires
judicious control over several experimental parameters in order to
achieve emulsion stability. In order to obtain suitable emulsions for
the encapsulation of farnesol, several concentrations for Tween 20
and Span 80 were investigated and here results are presented among
those that result in themoremorphological uniform droplets as eval-
uated by optical microscopy. Moreover, the droplets average size and
size distribution have a major role in the emulsion stability in a way
that emulsions with precisely controlled droplet size exhibit better
stability. As the interfacial curvature of the internal droplets is tensed
due to the small size of the droplets, the addition of surfactant in
the external phase will help the formation of a hole in the external
ﬁlm when the internal drops are close to the surface. This enables
a decrease of the curvature tension that becomes more positive and
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Table 1
Chemical composition of the emulsions used for the fabrication of SiO2 capsules.
Formulation Primary O/W External oil phase
Tween 20 NH4OH PEG PVP P123
Internal
oil phase* HPC Span 80
E1 (retinol) (wt%) 1 2 0.6 4 0.8 2
E2 (retinol) (wt%) 1 2 0.6 4 0.8 2
E3 (retinol) (wt%) 1 2 0.6 4 0.8 2
E4 (O.A.) (wt%) 1 2 0.6 4 0.8 2
E5 (O.A.) (wt%) 1 2 0.6 4 0.8 2
E6 (O.A.) (wt%) 1 2 0.6 4 0.8 2
∗ The internal oil phase, composed by the vehicle and farnesol were prepared using 3.96 (wt%) of the vehicle and 0.04 (wt%) of farnesol. O.
A.—oleic acid.
Fig. 1. Optical microscope images of O/W/O emulsions: formulation E6 (top);
formulation E5 (bottom).
therefore entropically favorable. In this regards, additional stabilizers
such as HPC, PEG, PVP and P123 were used in this study to improve
the stability of both external oil and water phases as reported else-
where [19]. Fig. 1 shows an optical microphotograph of typical O/W/
O multiple emulsions employed in this study. These emulsions were
used immediately after their preparation.
Because TEOS was added to O/W/O emulsions as precursor of the
sol–gel method, amorphous SiO2 forms through a series of hydrol-
ysis and condensation reactions involving oligomeric silane species
at the O/W interphase. The literature reports attempts to explain
the mechanism of formation of SiO2 via the sol–gel method using
microemulsions as nanoreactors [1]. In brief, TEOS that is initially
solubilized in the oil phase migrate to the O/W interphase where hy-
drolysis and condensation occurs. The formed hydrophilic oligomers
act as precursor species for the growth of an amorphous siliceous
Fig. 2. FT-IR spectra of formulation E6 after keeping the sample at 60 ◦C for distinct
times. Highlighted spectral regions show contribution from farnesol.
network in the inner water phase. The infrared spectra of the cap-
sules are dominated by characteristic bands of amorphous SiO2 (Fig.
2). Thus the bands centered at 1095 and 465 cm−1 are respectively at-
tributed to asymmetric and symmetric Si–O–Si stretching vibrations
of the silica shells. A weak absorption band at 955 cm−1 and a broad
band at about 3427–3456 cm−1 are respectively assigned to Si–OH
bending and stretching modes [25]. Note that vibrational bands of
the organic compounds employed in the encapsulation process have
also been detected though a unequivocal assignment was not possi-
ble due to overlap of bands due to the presence of several compounds
in the capsules. Nevertheless, the spectral regions between 2966–
2854 cm−1 and 1380–1327 cm−1, in which the C–H stretching and
bending modes of pure farnesol are observed, have been analysed
in more detail. Thus the IR spectra of the capsules were recorded at
distinct times after keeping the sample at 60 ◦C. Fig. 2 shows a typical
behavior for the formulation E6, revealing a decrease of the bands
intensities in the spectral regions mentioned above, which is a ﬁrst
indication of slow release of farnesol.
The release behavior of retinol has been investigated in SiO2 cap-
sules, mainly due to its relevance as a skin cosmetic [1,19]. Therefore,
in the present work this compound was also used as a vehicle for far-
nesol in SiO2 capsules to obtain materials that combine the beneﬁts
of both compounds. However, because retinol is expensive, oleic acid
was also investigated here as an alternative lipophilic vehicle, which
though not presenting the retinol bioactivity is less expensive. Fig. 3
shows SEM images for SiO2 capsules prepared using distinct vehicles
(retinol and oleic acid) and for the several formulations investigated.
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Fig. 3. SEM images of capsules prepared in O/W/O emulsions. Upper pannel: formu-
lations using retinol as vehicle: (A) E1, (B) E2 and (C) E3; bottom pannel: formulations
using oleic acid as vehicle: (D) E4, (E) E5 and (F) E6.
Although the SiO2 capsules appear as spheroidal particles with rough
surfaces using either retinol or oleic acid, the presence of PEG (formu-
lations E1 and E4) seems necessary to control the polydispersity of
the system. It should be noted that the stabilizers dissolved in thewa-
ter phase have a strong inﬂuence on the size and morphology of the
capsules prepared in the presence of either retinol or oleic acid. The
particles were in average slightly bigger for formulations containing
PVP as compared to those in which PEG and P123 were employed.
On the other hand, the use of PEG in water phase result in spheri-
cal capsules with a porous surface (Fig. 3A and 3D), with the use of
retinol leading to capsule surfaces smother than those obtained in the
presence of oleic acid.
TEM analysis was performed on selected samples (E1 and E4) de-
scribed above in order to elucidate the type of internalmicrostructure
of the capsules. The TEM images shown in Fig. 4 indicate that the cap-
sules aremadeof porous shells,which in turn are composedof smaller
SiO2 particles. Therefore the silica capsules formed in O/W/O multi-
ple emulsions seem to result from the assembly of nanosized silica
previously formed during the sol–gel process. The assembly of these
SiO2 nanoparticles into shells occurs preferentially in thewater phase
thus yielding a porous material in which the nanoparticles are ﬁlled
with the lipophilic substances present in the inner oil phase.
The in vitro release of farnesol from the capsules in function of
time was investigated either in the vapor phase or by redispersing
the silica in ethanol. The curves of drug release from SiO2 obtained
in different formulations are shown in Fig. 5. The results show that
the capsules exhibit a controlled release of farnesol. Taking in con-
sideration the analytical methods employed in each case, the release
proﬁles seemcomparable for each sample analysed in the vapor phase
and in ethanol.
The polymer used as stabilizer in the water phase inﬂuences the
morphology/surface of the as prepared SiO2 capsules, therefore it is
expected that the capsule morphological features inﬂuence the re-
lease proﬁle of farnesol. However, the most striking feature in Fig. 5
is the distinct release proﬁle observed when using capsules of for-
mulation E1, as compared to the other SiO2 samples, in both release
media. For example, the stabilizer employed in E1 and E4 formula-
tions was PEG, in both cases, leading to capsules that share similar
morphologies, namely a porous surface (Fig. 3) and still exhibit dis-
tinct release behavior. Although in these cases the SiO2 capsules have
distinct mean diameters, respectively 0.94μm (S.D. = 0.32μm) and
0.44μm (S.D. = 0.13μm) for E1 and E4, the sizes estimated for the
capsules are of the same order of magnitude. Thus it is unlikely that
the release behavior results solely from differences on the morpho-
logical characteristics of the capsules. A possible explanation relies
on a conjugated effect arising not only from differences in the size
of the capsules but also on the type of interactions between farnesol
molecules and the vehicle, retinol or oleic acid. The lower release
was observed for E4, which may infer that stronger interactions be-
tween farnesol and oleic acid had occurred, in fact both compounds
Fig. 4. TEM images of SiO2 capsules prepared in O/W/O emulsions using
formulations E1 (top) and E4 (bottom).
are composed of long unsaturated alkyl chains with a polar head.
4. Conclusions
In this research, it was demonstrated for the ﬁrst time the di-
rect encapsulation of farnesol into amorphous silica capsules using
multiple emulsions. All systems analysed exhibit good sustained re-
lease properties for this bioactive compound. In particular, the cap-
sules prepared in the presence of PEG and using retinol as the ve-
hicle showed intense release over a short initial period of time, as
compared to capsules prepared using other formulations. It is well
known that terpene compounds (e.g. trans,trans-farnesol) are praised
for their beneﬁcial effects to human health, namely as anti-oxidant
agents. The release proﬁles reported here are compatible with the
needs of an anti-oxidant effect in fast stress oxidative situations or in
cases of a preventive action for longer periods of time. Noteworthy,
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Fig. 5. Release of farnesol from SiO2 capsules prepared in O/W/O multiple emulsions
in function of time. A: Vapor phase; B: Ethanol medium.
farnesol can be obtained from grape pomace, which is a by product
of the wine industry, thus in line with the strategy described here
to develop non-expensive capsules for cosmetics, in particular those
carrying oleic acid as the vehicle. Moreover, considering recent de-
velopments on the production of highly sophisticated nanocapsules
[26], the materials reported here can be further exploited in contexts
aiming multifunctionality.
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